Mictonorm (Propiverine Hydrochloride)

Propiverine works by competitively blocking muscarinic (M3) receptors in the detrusor muscle of the bladder, preventing acetylcholine‑induced contractions. This anticholinergic action reduces involuntary bladder activity, while its mild calcium‑channel blocking effect further relaxes the bladder smooth muscle.

The appropriate dose of Mictonorm is determined by the prescribing healthcare professional based on the individual’s condition, age, renal function, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for propiverine during pregnancy and lactation are limited. It should only be used when the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To request Mictonorm, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mictonorm belongs to the antimuscarinic class, similar to oxybutynin. Compared with oxybutynin, propiverine may have a lower incidence of dry mouth and may provide a longer duration of action, but individual response varies and the choice depends on patient tolerance and clinician judgment.

Mictonorm tablets should be stored at ambient temperature, preferably below 25 °C, in their original packaging to protect them from moisture and light. Keep the product out of reach of children and do not use after the expiry date.

Mictonorm is taken orally, usually with water. The tablet should be swallowed whole and not chewed or crushed, unless otherwise directed by a healthcare professional. It is typically taken once daily, but exact timing is determined by the prescriber.

Serious adverse events include acute urinary retention, severe allergic reactions such as rash or anaphylaxis, and cardiac arrhythmias. Patients should seek immediate medical attention if they experience difficulty urinating, swelling, breathing problems, or irregular heartbeats.

Mictonorm is contraindicated in patients with known hypersensitivity to propiverine or any excipients, those with severe urinary retention or bladder outlet obstruction, and individuals for whom anticholinergic therapy is medically inadvisable. A healthcare professional should evaluate suitability before prescribing.